vs
Side-by-side financial comparison of VINCE HOLDING CORP. (VNCE) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
VINCE HOLDING CORP. is the larger business by last-quarter revenue ($85.1M vs $70.6M, roughly 1.2× Viridian Therapeutics, Inc.\DE). VINCE HOLDING CORP. runs the higher net margin — 3.2% vs -49.0%, a 52.2% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 6.2%). VINCE HOLDING CORP. produced more free cash flow last quarter ($-5.7M vs $-84.7M).
VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
VNCE vs VRDN — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $70.6M |
| Net Profit | $2.7M | $-34.6M |
| Gross Margin | 49.2% | — |
| Operating Margin | 6.4% | -56.7% |
| Net Margin | 3.2% | -49.0% |
| Revenue YoY | 6.2% | 81958.1% |
| Net Profit YoY | -37.3% | 54.9% |
| EPS (diluted) | $0.21 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | — | ||
| Q3 25 | $73.2M | $70.6M | ||
| Q2 25 | $57.9M | — | ||
| Q1 25 | $80.0M | — | ||
| Q4 24 | $80.2M | — | ||
| Q3 24 | $74.2M | — | ||
| Q2 24 | $59.2M | — | ||
| Q1 24 | $75.3M | — |
| Q4 25 | $2.7M | — | ||
| Q3 25 | $12.1M | $-34.6M | ||
| Q2 25 | $-4.8M | — | ||
| Q1 25 | $-28.3M | — | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $569.0K | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $-4.7M | — |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 50.3% | — | ||
| Q1 25 | 50.1% | — | ||
| Q4 24 | 50.0% | — | ||
| Q3 24 | 47.4% | — | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 45.4% | — |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 15.2% | -56.7% | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | -37.1% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 9.5% | — | ||
| Q1 24 | -2.2% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.5% | -49.0% | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -35.5% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | -6.2% | — |
| Q4 25 | $0.21 | — | ||
| Q3 25 | $0.93 | — | ||
| Q2 25 | $-0.37 | — | ||
| Q1 25 | $-2.25 | — | ||
| Q4 24 | $0.34 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.35 | — | ||
| Q1 24 | $-0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $53.4M | $503.0M |
| Total Assets | $246.0M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | — | ||
| Q3 25 | $777.0K | $490.9M | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $607.0K | — | ||
| Q4 24 | $892.0K | — | ||
| Q3 24 | $711.0K | — | ||
| Q2 24 | $739.0K | — | ||
| Q1 24 | $357.0K | — |
| Q4 25 | $53.4M | — | ||
| Q3 25 | $49.3M | $503.0M | ||
| Q2 25 | $37.2M | — | ||
| Q1 25 | $41.8M | — | ||
| Q4 24 | $57.1M | — | ||
| Q3 24 | $52.4M | — | ||
| Q2 24 | $51.7M | — | ||
| Q1 24 | $47.2M | — |
| Q4 25 | $246.0M | — | ||
| Q3 25 | $239.0M | $577.1M | ||
| Q2 25 | $218.0M | — | ||
| Q1 25 | $222.7M | — | ||
| Q4 24 | $254.7M | — | ||
| Q3 24 | $253.6M | — | ||
| Q2 24 | $223.1M | — | ||
| Q1 24 | $225.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.1M | $-84.6M |
| Free Cash FlowOCF − Capex | $-5.7M | $-84.7M |
| FCF MarginFCF / Revenue | -6.7% | -120.1% |
| Capex IntensityCapex / Revenue | 0.7% | 0.2% |
| Cash ConversionOCF / Net Profit | -1.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.1M | — | ||
| Q3 25 | $4.2M | $-84.6M | ||
| Q2 25 | $-11.8M | — | ||
| Q1 25 | $22.7M | — | ||
| Q4 24 | $6.4M | — | ||
| Q3 24 | $-3.2M | — | ||
| Q2 24 | $-3.9M | — | ||
| Q1 24 | $14.8M | — |
| Q4 25 | $-5.7M | — | ||
| Q3 25 | $2.1M | $-84.7M | ||
| Q2 25 | $-13.2M | — | ||
| Q1 25 | $21.2M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $-3.9M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $14.2M | — |
| Q4 25 | -6.7% | — | ||
| Q3 25 | 2.9% | -120.1% | ||
| Q2 25 | -22.9% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | -5.2% | — | ||
| Q2 24 | -7.8% | — | ||
| Q1 24 | 18.9% | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 2.9% | 0.2% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | -1.86× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | -5.61× | — | ||
| Q2 24 | -0.89× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
VRDN
Segment breakdown not available.
